PMH40 COST-EFFECTIVENESS AND BUDGET IMPACT OF ADJUNCT QUETIAPINE FUMARATE EXTENDED-RELEASE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AN INADEQUATE RESPONSE TO PREVIOUS THERAPY
May 1, 2011, 00:00
10.1016/j.jval.2011.02.1064
https://www.valueinhealthjournal.com/article/S1098-3015(11)01203-4/fulltext
Title :
PMH40 COST-EFFECTIVENESS AND BUDGET IMPACT OF ADJUNCT QUETIAPINE FUMARATE EXTENDED-RELEASE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AN INADEQUATE RESPONSE TO PREVIOUS THERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01203-4&doi=10.1016/j.jval.2011.02.1064
First page :
A192
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
543